Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient ... Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts. Show more
Allurion Technologies, Inc. (βAllurionβ or the βCompanyβ) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a definitive securities purchase agreement...
Allurion Technologies, Inc. (βAllurionβ or the βCompanyβ) (NYSE: ALUR), a company dedicated to ending obesity, today announced its intention to initiate a clinical study on the combination of the...
Allurion Technologies, Inc. (βAllurionβ or the βCompanyβ) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has received an Issue Notification from the U.S. Patent and...
Allurion Technologies, Inc. (βAllurionβ or the βCompanyβ) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a subscription agreement with funds...
At 48 weeks, Allurion Balloon subjects had a greater than 50% responder rate and substantially greater weight loss than Control subjects Low rate of serious adverse events supports favorable...
Allurion Technologies, Inc. (NYSE: ALUR) (βAllurionβ or the βCompanyβ), a company dedicated to ending obesity, today announced that its Board of Directors has determined to effect a...
Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it received an Acceptance Letter from the Listings Operations Committee of the New York Stock...
AllurionMeds is designed to address a critical demand from patients: The Weight Must Stay Off Features Coach Iris, a first-of-its-kind conversational AI behavioral agent for weight loss and...
Allurion Technologies, Inc. (NYSE: ALUR) (βAllurionβ or the βCompanyβ), a company dedicated to ending obesity, today announced its financial results for the third quarter ended September 30, 2024...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -10.99 | -65.4556283502 | 16.79 | 16.86 | 5.04 | 14507023 | 8.53175621 | CS |
4 | -4.83 | -45.4374412041 | 10.63 | 16.86 | 2.3669 | 4380716 | 8.41639676 | CS |
12 | -13.2 | -69.4736842105 | 19 | 19.124975 | 2.3669 | 1885584 | 8.80693047 | CS |
26 | -15.7 | -73.023255814 | 21.5 | 22.625 | 2.3669 | 911721 | 9.64825637 | CS |
52 | -70.45 | -92.393442623 | 76.25 | 98.75 | 2.3669 | 1033065 | 41.51012479 | CS |
156 | -219.2 | -97.4222222222 | 225 | 225 | 2.3669 | 714777 | 44.41727316 | CS |
260 | -219.2 | -97.4222222222 | 225 | 225 | 2.3669 | 714777 | 44.41727316 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.